Clinical Trials Directory

Trials / Completed

CompletedNCT01173965

Endometrial Ablation With Non-hysteroscopic Methods

Treatment of Dysfunctional Uterine Bleeding With Second Generation Ablation Devices: Microwaves (MEA®) vs Bipolar Impedance Control System (Novasure®)

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
66 (actual)
Sponsor
Aristotle University Of Thessaloniki · Academic / Other
Sex
Female
Age
30 Years – 49 Years
Healthy volunteers
Not accepted

Summary

Endometrial ablation in women with dysfunctional uterine bleeding using second generation ablation devices is a common widespread therapeutic approach. This study aims to prove that amenorrhoea rates using Novasure are higher than those observed in microwave endometrial ablation, one year following intervention.

Conditions

Interventions

TypeNameDescription
DEVICEMEAMicrowave endometrial ablation device
DEVICENovasureBipolar impedence control system

Timeline

Start date
2008-01-01
Primary completion
2010-02-01
Completion
2011-02-01
First posted
2010-08-03
Last updated
2012-07-12

Locations

2 sites across 1 country: Greece

Source: ClinicalTrials.gov record NCT01173965. Inclusion in this directory is not an endorsement.

Endometrial Ablation With Non-hysteroscopic Methods (NCT01173965) · Clinical Trials Directory